A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...

Japan has approved two pioneering stem-cell therapies for the treatment of Parkinson’s disease and severe heart failure, marking a major milestone in ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

The International Society for Stem Cell Research (ISSCR) is pleased to announce Stem Cell COREdinates and CorEUstem as the recipients of the 2026 ISSCR Public Service Award. Together, these two global ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

A team led by University of Osaka researchers has developed a technique to generate testes from mouse embryonic stem cells ...

Conditional approval marks a global milestone in regenerative medicine; treatments could reach patients this summer - Anadolu ...

The big picture: Nearly two decades ago, Shinya Yamanaka and Kazutoshi Takahashi discovered they could turn mature somatic cells back into stem cells. The scientists predicted these new cells could be ...

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...